These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8844812)

  • 1. Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis.
    Kadlubar F; Kaderlik RK; Mulder GJ; Lin D; Butler MA; Teitel CH; Minchin RF; Ilett KF; Friesen MD; Bartsch H
    Princess Takamatsu Symp; 1995; 23():207-13. PubMed ID: 8844812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
    Badawi AF; Stern SJ; Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyltransferase-dependent activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine: formation of 2-amino-1-methyl-6-(5-hydroxy)phenylimidazo [4,5-b]pyridine, a possible biomarker for the reactive dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Frandsen H; Alexander J
    Carcinogenesis; 2000 Jun; 21(6):1197-203. PubMed ID: 10837010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of glucuronidation on the bioactivation and DNA adduction of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in vivo.
    Malfatti MA; Ubick EA; Felton JS
    Carcinogenesis; 2005 Nov; 26(11):2019-28. PubMed ID: 15944213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urinary metabolite profile of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is predictive of colon DNA adducts after a low-dose exposure in humans.
    Malfatti MA; Dingley KH; Nowell-Kadlubar S; Ubick EA; Mulakken N; Nelson D; Lang NP; Felton JS; Turteltaub KW
    Cancer Res; 2006 Nov; 66(21):10541-7. PubMed ID: 17079477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse.
    Leff MA; Epstein PN; Doll MA; Fretland AJ; Devanaboyina US; Rustan TD; Hein DW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):182-7. PubMed ID: 10381774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The capability of rat colon tissue slices to metabolize the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Malfatti MA; Connors MS; Mauthe RJ; Felton JS
    Cancer Res; 1996 Jun; 56(11):2550-5. PubMed ID: 8653696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine-induced DNA adducts and genotoxicity in chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N-acetyltransferase 2.
    Metry KJ; Zhao S; Neale JR; Doll MA; States JC; McGregor WG; Pierce WM; Hein DW
    Mol Carcinog; 2007 Jul; 46(7):553-63. PubMed ID: 17295238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
    Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
    Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.
    Lin DX; Lang NP; Kadlubar FF
    Drug Metab Dispos; 1995 Apr; 23(4):518-24. PubMed ID: 7600922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
    Nelson CP; Kidd LC; Sauvageot J; Isaacs WB; De Marzo AM; Groopman JD; Nelson WG; Kensler TW
    Cancer Res; 2001 Jan; 61(1):103-9. PubMed ID: 11196146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans: relationship to cytochrome P4501A2 and N-acetyltransferase activity.
    Stillwell WG; Kidd LC; Wishnok JS; Tannenbaum SR; Sinha R
    Cancer Res; 1997 Aug; 57(16):3457-64. PubMed ID: 9270013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred rats.
    Purewal M; Velasco M; Fretland AJ; Hein DW; Wargovich MJ
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):529-32. PubMed ID: 10815700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of DNA adduct formation of PhIP in female F344 rats by dietary conjugated linoleic acid.
    Josyula S; He YH; Ruch RJ; Schut HA
    Nutr Cancer; 1998; 32(3):132-8. PubMed ID: 10050262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues.
    Kaderlik KR; Minchin RF; Mulder GJ; Ilett KF; Daugaard-Jenson M; Teitel CH; Kadlubar FF
    Carcinogenesis; 1994 Aug; 15(8):1703-9. PubMed ID: 8055652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4, 5-f]quinoline.
    Agus C; Ilett KF; Kadlubar FF; Minchin RF
    Carcinogenesis; 2000 Jun; 21(6):1213-9. PubMed ID: 10837012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline.
    King RS; Teitel CH; Kadlubar FF
    Carcinogenesis; 2000 Jul; 21(7):1347-54. PubMed ID: 10874013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer.
    Zhu J; Chang P; Bondy ML; Sahin AA; Singletary SE; Takahashi S; Shirai T; Li D
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):830-7. PubMed ID: 14504191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline.
    Metry KJ; Neale JR; Bendaly J; Smith NB; Pierce WM; Hein DW
    Drug Metab Dispos; 2009 Nov; 37(11):2123-6. PubMed ID: 19666988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A2 and NAT2 genotype/phenotype relations and urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in a human dietary intervention study.
    Moonen HJ; Moonen EJ; Maas L; Dallinga JW; Kleinjans JC; de Kok TM
    Food Chem Toxicol; 2004 Jun; 42(6):869-78. PubMed ID: 15110095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.